SB 1230
Initials AG/BG Page 1 Appropriations
ARIZONA HOUSE OF REPRESENTATIVES
Fifty-seventh Legislature
First Regular Session
Senate: HHS DP 6-0-1-0 | APPROP DP 7-3-0-0 | 3rd Read 23-6-1-0
House: HHS DPA 7-4-0-1
SB 1230: marijuana; clinical research trials
Sponsor: Senator Payne, LD 27
Committee on Appropriations
Overview
Requires, rather than allows, monies in the Medical Marijuana Fund (Fund) to be used to
provide grants for marijuana clinical trials. Instructs the Arizona Biomedical Research
Centre to provide $2,000,000 by July 1, 2026, and an additional $2,000,000 by July 1, 2028,
to administer and award competitive grants for the marijuana clinical trials. Contains a
Proposition 105 clause.
History
Administered by the Arizona Department of Health Services (DHS), the Medical Marijuana
Fund is established consisting of fees collected, civil penalties imposed and private donations.
Monies in the Fund may be used to provide grants for marijuana clinical trials (A.R.S. § 36-
2817).
The Arizona Biomedical Research Centre (ABRC) in DHS must provide competitive grants
from monies in the Fund for marijuana clinical trials that are approved by the U.S. Food and
Drug Administration (FDA) for evaluating both the safety and efficacy of using marijuana in
humans and researching the impacts of marijuana interactions with prescription drugs,
nonprescription drugs and illicit drugs. The ABRC may provide up to $5,000,000 annually
for five consecutive years from the Fund and are prohibited from using more than five percent
of these monies for administrative purposes.
Clinical trials funded are required to be conducted by Arizona-based researchers from
nonprofit organizations or universities, be approved by the FDA, the U.S. Drug Enforcement
Administration and an institutional review board and be publishable in peer-reviewed
medical and public health journals (A.R.S. § 36-2822).
Provisions
1. Requires, rather than allows, monies in the Fund to be used to provide grants for
marijuana clinical trials. (Sec. 1)
2. Directs, by July 1, 2026, the ABRC to provide $2,000,000 from the Fund to administer
and award competitive grants for marijuana clinical trials. (Sec. 2)
3. Requires, by July 1, 2028, the ABRC to provide an additional $2,000,000 from the Fund
to administer and award competitive grants if DHS determines the Fund:
a) has at least two years of operational expenses; and
b) will not be at risk of a deficit or require an increase in registry identification card fees.
(Sec. 2)
☒ Prop 105 (45 votes) ☐ Prop 108 (40 votes) ☐ Emergency (40 votes) ☐ Fiscal Note SB 1230
Initials AG/BG Page 2 Appropriations
4. Contains a Proposition 105 clause. (Sec. 3)
5. Makes a technical change. (Sec. 1)